Icon

THALOMID (nda020785)- (50MG,100MG,150MG,200MG)

THALIDOMIDE BRISTOL-MYERS
50MG,100MG,150MG,200MG
Yes No
2023-Dec-09 Expired
2013-May-25 None
None No
THALOMID in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma (MM). THALOMID is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). THALOMID is not indicated as monotherapy for such ENL treatment in the presence of moderate to severe neuritis. THALOMID is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence.
1 0 0
Total Other Developers 1
Drugs with Suitability No
50MG ** ** - - -
100MG ** ** - - -
150MG ** ** - - -
200MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.